Covington Associates Research
Advisory Approach
Covington Associates is a premier boutique investment banking firm founded in 1991 and headquartered in Boston. For over 30 years, the firm has maintained a singular mission: provide middle-market clients with the highest caliber senior-level attention based on advice-driven and results-focused principles. The firm operates with a thesis that superior client service comes from deep industry expertise, long-term relationship building, and customized strategies tailored to each client's unique situation.
Covington distinguishes itself through its specialized focus and continuity—many team members have been with the firm for 15-25 years, creating institutional knowledge and deep client relationships that span decades. The firm's approach emphasizes senior-level attention throughout all phases of transactions, with Managing Directors personally involved from initial engagement through closing, not just during business development.
Sector Focus
Covington's practice is heavily concentrated in Healthcare, which represents approximately 80%+ of their transaction volume. Within healthcare, the firm has developed particular depth in:
Healthcare Services: Infusion therapy, durable medical equipment (DME), specialty pharmacies, healthcare IT, and contract research organizations (CROs). The firm has completed numerous transactions in home and ambulatory infusion, point-of-care technology, and market access services.
Healthcare Products/Technology: Medical devices, precision medical components, tubing and extrusion for life sciences, diagnostic products, and hospital pharmacy technology. The firm has advised on transactions involving companies that serve medical OEMs, hospital systems, and point-of-care providers.
Technology and Software: While primarily healthcare-focused, Covington also works with technology-enabled services and software companies, particularly those with healthcare applications or B2B SaaS models.
The firm also maintains capabilities in Business Services and Consumer & Industrial sectors, though these represent smaller portions of their deal flow.
Deal Track Record
Since its founding in 1991, Covington Associates has completed over 350 transactions globally for both private and publicly traded companies, totaling more than $30 billion in aggregate transaction value. The firm's transaction history demonstrates consistent activity across market cycles, with multiple deals completed annually from the late 1990s through 2025.
Recent transactions (2020-2025) include:
2025: Argos Corporation (precision extrusion) to Aptyx; Care Fusion Rx (infusion therapy) merger with Reliant Healthcare; Persivia (AI-driven digital health) $107M recapitalization with Aldrich Capital Partners
2022: Casimir (rare disease CRO) to Emmes/Behrman Capital; CheckedUp (digital point-of-care technology) investment by Rockbridge Growth Equity; PRIA Healthcare (market access services) recapitalization by Aldrich Capital Partners
2021: Summit Xpress (urological supplies) to Strive Medical/NMS Capital; CloudWave (healthcare cloud services) recapitalization by Abry Partners; WellCare recapitalization by Corbel Capital Partners
2020: Med Tech Solutions (healthcare IT) recapitalization by Sunstone Partners
2019: Midé Technology Corporation (aerospace/industrial engineering) to Hutchinson Corporation/Total
2018: Bridgemedica (medical device design/manufacturing) to NN, Inc.; MedKeeper (hospital pharmacy software) majority stake to Grifols; Dura Medic (DME) recapitalization by Comvest Partners
Historically significant transactions include the $1.3 billion sale of Inverness Medical Technology to Johnson & Johnson and advisory roles on over 30 transactions for a single client that grew from $40M to $2B in revenue.
Process & Fee Structure
Covington runs institutional-quality, boutique sell-side processes tailored to lower middle market companies. Their process emphasizes:
- Comprehensive buyer outreach to strategic acquirers and financial sponsors
- Senior-level involvement throughout the engagement
- Customized marketing materials and go-to-market strategies
- Hands-on management of due diligence and buyer communications
Transaction sizes typically range from $25 million to $500 million in enterprise value, with capacity for transactions up to $1 billion+. The firm has completed transactions ranging from $5 million to over $1 billion.
Fee structures follow industry standards for lower middle market investment banks, typically:
- Success fees: Modified Lehman or similar percentage-based structures on total enterprise value
- Retainers: Monthly fees during engagement, credited against success fees
- Minimum engagement size: Approximately $10-15 million TEV floor
The firm requires exclusivity and typically focuses on founder-owned, family-owned, and privately-held businesses seeking sell-side advisory, recapitalizations, or strategic alternatives guidance.
Buyer Network
Covington maintains relationships with thousands of potential buyers across strategic acquirers and private equity firms. Their deal history shows transactions with:
Private Equity Buyers: Aptyx/TruArc Partners, Aldrich Capital Partners, Rockbridge Growth Equity, Abry Partners, Sunstone Partners, NMS Capital, Comvest Partners, Behrman Capital, Corbel Capital Partners, Shore Capital Partners, Grifols, Genstar Capital
Strategic Buyers: Johnson & Johnson, Hutchinson Corporation/Total, NN, Inc., Aptyx, Emmes, Strive Medical, Reliant Healthcare
The firm has particular strength in healthcare-focused private equity and strategic buyers in medical devices, healthcare services, and healthcare IT. Covington's co-founded private equity affiliate, Pleasant Bay Capital Partners (established 2012), provides additional deal flow and buyer relationships.
Competitive Positioning
Covington Associates differentiates through:
-
Longevity and Stability: Founded in 1991 with many team members having 15-25 year tenures, creating institutional knowledge and client relationships that span decades
-
Healthcare Specialization: 80%+ of transactions in healthcare, with deep expertise across healthcare services, products, and technology subsectors
-
Senior-Level Attention: Managing Directors are hands-on throughout the entire transaction process, not just during business development
-
Boutique Service, Institutional Quality: Combines personalized attention of a boutique with process rigor and buyer networks typically found at larger firms
-
Private Equity Affiliation: Through Pleasant Bay Capital Partners, the firm offers unique perspectives from both sides of transactions
Not a Fit If
Covington typically declines:
- Businesses below $10-15 million TEV
- Transactions requiring extensive financing capability beyond their capital markets relationships
- Industries outside their core expertise (heavy industrials, energy, real estate, financial services)
- Founders wanting limited process or speed-focused transactions
Team
The firm has approximately 18-20 professionals led by 9 Managing Directors:
Chris Covington (Founder & Managing Director): Founded Covington in 1991 after 15 years at Shearson/American Express and co-founding Volpe & Covington. 40+ years of M&A experience with significant healthcare and technology expertise. Williams College and Harvard Business School graduate.
Tom Cibotti (Managing Director): Joined Covington in 1993 with 20+ years of transaction experience. Key roles in $1.3B Inverness Medical to Johnson & Johnson sale and $1.8B Biosite acquisition. Boston College and NYU MBA.
Ben Dunn (Managing Director): 25+ years in healthcare M&A, completed 100+ medical technology transactions. Expert in global medical devices and outsourcing. Frequent speaker at healthcare conferences.
Scott Fisher (Managing Director): Joined 2013 with 25+ years in M&A, corporate development, and principal investing. Focuses on pharmaceutical services, CROs, CDMOs, and healthcare IT. Also Managing Director at Pleasant Bay Capital Partners. Harvard Business School MBA.
Grant Grava (Managing Director): Joined 2010 with 20+ years of diversified M&A experience. Previously at Jefferies, SG Cowen, and Prudential Securities. Columbia MBA.
Andrew Johnson (Managing Director): Joined 2015 with 10+ years of transaction and client advisory experience. Previously at LP Capital Advisors and GE's Financial Management Program.
Tim McMahon (Managing Director): Joined 2005 with 20+ years in investment banking. Previously President/CEO of Adams Harkness Inc., where he oversaw investment banking expansion. Boston University and Babson MBA.
Chris Tashjian (Managing Director): Joined 2009 with 20-year career in lower middle-market sell-side M&A. Focuses on healthcare, business services, and software/technology. Previously at Provident Healthcare Partners.
James Vandervelden (Managing Director): Joined 2012 with 30+ years of private equity and M&A experience. Co-founded Pleasant Bay Capital Partners. Previously at Ticonderoga Capital, Dillon Read, and TA Associates. Brown University graduate.
Additional team includes Directors, Vice Presidents, and Analysts with backgrounds from PwC, Boston Scientific, Partners Healthcare, and equity research firms.
Geographic Coverage
Headquartered in Boston at 99 Summer Street. Serves clients nationally with particular strength in Northeast healthcare ecosystem but completes transactions across all U.S. regions. International capability through relationships with European strategic buyers and cross-border transactions.